Bionano Genomics
BNGO
12 hedge funds and large institutions have $482K invested in Bionano Genomics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
33% more funds holding
Funds holding: 9 → 12 (+3)
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
76% less capital invested
Capital invested by funds: $2.01M → $482K (-$1.53M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
| 2 |
Bank of New York Mellon
New York
|
+$44K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$39K |
| 4 |
BlackRock
New York
|
+$18.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$1.5M |
| 2 |
Two Sigma Investments
New York
|
-$71K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$14K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$5.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank Julius Baer & Co
Zurich,
Switzerland
| $205K | +$426K | +755 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $112K | -$5.08K | -9 | -2% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $92K | +$190K | +336 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $24K | +$39K | +69 | +406% |
|
|
5
Bank of New York Mellon
New York
| $21K | +$44K | +78 | New |
|
|
6
BlackRock
New York
| $12K | +$18.6K | +33 | +254% |
|
|
7
Northern Trust
Chicago,
Illinois
| $11K | +$10.7K | +19 | +83% |
|
8
Victory Capital Management
San Antonio,
Texas
| $4K | +$9.6K | +17 | New |
|
|
AF
9
Advisornet Financial
Minnetonka,
Minnesota
| $1K | +$1.69K | +3 | New |
|
|
SCM
10
Sio Capital Management
New York
| – | -$1.5M | -2,018 | Closed |
|
|
11
Two Sigma Investments
New York
| – | -$71K | -96 | Closed |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$14K | -18 | Closed |
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$565 | +1 | New |
|
|
ASN
14
Advisory Services Network
Atlanta,
Georgia
| – | +$1.13K | +2 | New |
|
BNGO Hedge Fund Activity: Q1 2020 in Review
12 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2020, worth a combined $482K — down 76% from $2.01M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BNGO positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $190K. The largest seller was Sio Capital Management, exiting entirely with an estimated $1.5M sold.
- 12 institutional investors held Bionano Genomics (BNGO) as of Q1 2020, up from 9 in Q4 2019.
- Funds reported $482K of Bionano Genomics stock for Q1 2020, down 76% quarter-over-quarter.
- 7 funds opened new Bionano Genomics positions in Q1 2020 and 3 closed out, a net change of +4 holders.
- The largest Bionano Genomics buyer in Q1 2020 was Vanguard Group, an estimated $190K added.
- The largest Bionano Genomics seller in Q1 2020 was Sio Capital Management, an estimated $1.5M sold.
Based on aggregated 13F filings for Q1 2020.